Inspire Medical Systems (INSP) Long-Term Investments (2019 - 2026)

Inspire Medical Systems has reported Long-Term Investments for 8 years, with the latest figure at $115.9 million in Q1 2026.

• Quarterly Long-Term Investments rose 158.49% year-over-year to $115.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.9 million (up 158.49% YoY) and the FY2025 annual result came in at $96.3 million, up 35.69% from the prior year.
• Long-Term Investments advanced to $115.9 million in Q1 2026 per INSP's latest filing, from $96.3 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $115.9 million in Q1 2026 and troughed at $3.0 million in Q3 2023.
• A 5-year average of $59.6 million and a median of $57.9 million in 2024 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2025: Long-Term Investments jumped 4701.96% in 2022, then declined 22.1% in 2025.
• Over 5 years, Long-Term Investments stood at $9.8 million in 2022, then declined by 6.67% to $9.1 million in 2023, then jumped by 676.5% to $71.0 million in 2024, then jumped by 35.69% to $96.3 million in 2025, then grew by 20.3% to $115.9 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $115.9 million, $96.3 million, and $88.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.